XOMA Corp
NASDAQ: XOMA
$26.09
+$0.27 (+1.0%)
Closing price April 23, 2024
Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look for high-conviction near-term binary events and lower conviction catalysts with...
Published:
Investors often hear about analyst upgrades and new “Buy” ratings. What they do not hear from most Wall Street analysts is the prediction that a stock price could double or come close to...
Published:
Last Updated:
The three major US equities indexes opened sharply lower this morning and the slide continued pretty much without interruption all day. About half an hour before closing, all three indexes are down...
Published:
Last Updated:
The three major US equities indexes opened sharply lower this morning as there has been no news to counteract the weak economic projections that came out yesterday. The projected -0.3% contraction in...
Published:
Xoma Ltd. (NASDAQ: XOMA) is getting crushed this morning on news that its potential Type-2 diabetes drug failed to lower blood sugar levels. The news is bad, but there are a few things here which...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Cree, Inc. (NASDAQ: CREE), Motricity, Inc. (NASDAQ: MOTR),...
Published:
Twitter has, by most estimates, 100 million members, which makes it one of the largest social networks in the world. All major media companies are on Twitter and some have more than one million...
Published:
These are the top day trader and active trader alerts seen in action this morning. We have details in the links over at VSInvestor.com with more details and analysis on each where applicable. Ambac...
Published:
Last Updated:
XOMA Ltd. (NASDAQ: XOMA) has seen shares on a tear yesterday and then again this morning. It was late yesterday that the company said it would also be entitled to royalties from its partner’s...
Published:
Last Updated:
AMAG Pharmaceuticals (NASDAQ: AMAG) has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI) beginning May 19, 2008. AMAG shares up $1.26 at $39.85. The 52-week range is $38.16 to $72.95. Cell...
Published:
Biopharmaceutical company Xoma (XOMA) is having its luck day. After its stock traded down as low as $2.24, its shares are up almost 20% today on news that it bacterial cell expression technology to...
Published: